Showing results (301-310 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|September 30, 2016
An efficient route to bispecific antibody production using single-reactor mammalian co-cultureWhitney Shatz, Domingos Ng, George Dutina, et al.Mabs|April 20, 2017
Infliximab crystal structures reveal insights into self-associationThomas F Lerch, Penelope Sharpe, Stephen J Mayclin, et al.Mabs|April 20, 2017
Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IVLisa C Schmitt, Alexander Rau, Oliver Seifert, et al.Mabs|March 23, 2019
Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffoldAdem C Koksal, Meghan E Pennini, Marcello Marelli, et al.Mabs|July 27, 2019
Specific and high-resolution identification of monoclonal antibody fragments detected by capillary electrophoresis-sodium dodecyl sulfate using reversed-phase HPLC with top-down mass spectrometry analysisWei-Han Wang, Jasmina Cheung-Lau, Yan Chen, et al.Mabs|July 18, 2019
Selection and characterization of FcεRI phospho-ITAM specific antibodiesNileena Velappan, Avanika Mahajan, Leslie Naranjo, et al.Mabs|February 21, 2014
Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvestGayle E Derfus, Jemelle Dizon-Maspat, Jared T Broddrick, et al.Mabs|March 18, 2017
Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1Salvatore Santamaria, Oleg Fedorov, John McCafferty, et al.Mabs|March 28, 2019
The impact of standard accelerated stability conditions on antibody higher order structure as assessed by mass spectrometryRichard A Kerr, David A Keire, Hongping YeMabs|March 17, 2021
Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cellsSivan Cohen, Srividya Myneni, Anna Batt, et al.Pageof 180